Human Papilloma Virus and oral cancer: Narrative review of the literature
Abstract
The Human Papilloma Virus (HPV) infection is now more common sexually transmitted diseases, with an incidence of 5.5 million worldwide, with 85% of the carrier of this virus adult population. Their oncogenic potential and increased oral lesions associated with oral HPV infection have led us to make a narrative of the literature on the role of HPV in oral cancer, especially types 16 and 18. Here we refer to the possible routes of infection, oncogenic mechanisms, both benign and potentially malignant oral lesions associated with the infection, different methods used for detection, prediction and prevention of infection. We stress the importance of the role of the dentist to identify individuals considered high risk and ease of performing detection in the oral cavity, through a quick and easy method as exfoliative cytology.
Keywords: oral cavity, squamous cell carcinoma, HPV 16, HPV 18
Virus Papiloma Humano y cáncer oral: Revisión narrativa de la literatura
El Virus Papiloma Humano (VPH) en la actualidad constituye la infección por transmisión sexual más frecuente, presentando una incidencia de 5,5 millones en el mundo, siendo un 85% de la población adulta portadora de este virus. Su potencial oncogénico y el aumento de lesiones orales asociadas a infección oral por VPH nos han llevado a realizar una narración de la literatura referente al rol del VPH en el cáncer oral, especialmente de los subtipos 16 y 18. Nos referiremos a sus posibles vías de contagio, mecanismos oncogénicos, lesiones orales tanto benignas como potencialmente malignas asociadas a su infección, diferentes métodos utilizados para su detección, pronóstico y prevención de contagio. Destacamos la importancia del rol del odontólogo para identificar individuos considerados de alto riesgo y la facilidad de realizar su detección en la cavidad oral, a través de un método rápido y sencillo como es la citología exfoliativa.
Palabras clave: cavidad bucal, carcinoma espinocelular, VPH 16, VPH 18.References
2. Campisi G, Panzarella V, Guiliani M, Lajolo C, Di Fede O, Falaschini S, Di Liberto C, Scully C, Lo Muzio L. Human papillomavirus: it's identikit and controversial rola in oral oncogenesis, premalignat and maligant lesions. Int J Oncol. 2007; 30(4): 813-23.
3. Kumaraswamy K, Vidhya M. Human Papilloma Virus and Oral infections: An Update. J Cancer Res Ther. 2011;7(2): 120-7.
4. Faridi R, Zahra A, Khan A, Idrees M. Oncogenic potencial of Human Papillomavirus (HPV) and its relaton with cervical cancer. Virol J. 2011; 8(269): 1-8.
5. Syrajän S, Lodi G, Von Bu¨Itzingslo¨wen I, Aliko A, Arduino P, Campisi G, Challacombe S, Ficarra G, Flaitz C, Zhou HM, Maeda H, Miller C, Jontell M. Human papilloma viruses in oral carcinoma and oral pontentially malignant disorders: a systematic review. Oral Dis. 2011; 17(1): 58-72.
6. Popóvic B, Jekic B, Novakovic I, Lukovic I, Konstantinovic , Babic M, Milasin J. Cancer Genes alterations and HPV infections in oral squamous cell carcinoma. Int J Oral Maxilofac Surg. 2010; 39(9): 909-15.
7. Serena E, Bologna R, Nevarez A, Rocha A. Prevalencia de VPH en el proceso de malignización de lesiones aérodigestivas superiores. Int J Odontostomat. 2011; 5(1): 5-12.
8. Doorbar J, Quint W, Banks L, Bravo I, Stoler M, Broker T, Stanley MA. The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30(5): 55-70.
9. Ha PK, Califano J. The Role of Human Papillomavirus in Oral Carcinogenesis. Crit Rev Oral Biol Med. 2004; 15(4):188-96.
10. Bonnez, William. Chapter 26 - Human Papillomarivus. In Barret A, Stanberry L. Vaccine for Biodefense and Emerging and Neglected Diseases. Rochester: Academic Press; 2009. p. 469-496.
11. Mannarini L, Kratachvil L, Calabrese L, Gomes P, Morbini J, Benazzo B. Human Papilloma Virus (HPV) in head and necl region. Acta Otorhinolaryngologia Italica. 2009; 29: 119-126.
12. Bernard H. The Clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol. 2006; 32: 1-6.
13. Pringle G. The role of human papillomavirus in oral disease. Dent Clin Nort Am. 2014; 58(2): 385-99.
14. Medina M, Medina M, Merino L. Consideraciones actuales sobre la presencia de papilomavirus humano en la cavidad oral. Av Odontoestomatol. 2010; 26(2): 71-80.
15. Neville BW, Damm DD, Allen CM, Bouquot JE. Chapter 10 Epithelial Pathology. In Neville BW, Damm DD, Allen CM, Bouquot JE. Oral and Maxillofacial Pathology.; 2009. p. 362-8.
16. Syrjänen S. Human Papillomavirus infections and oral tumors. Med Microbiol Immunol. 2013; 192: 123-8.
17. D Souza G, Agrawal Y, Halpern J, Bodison S, Gilson M. Oral Sexual behaviors associated with Prevalent Oral Human Papillomavirus Infection. J Infect Dis. 2009; 199: 1263-9.
18. Feller L, Lemmer J. Oral Leukoplakia as it relates to HPV infection: A Review. Int J Dent. 2012; 2012: 540561.
19. Park N-H, Kang MK. Genetic Instabilityt and Oral Cancer. Electron J Biotechnol. 2000; 3(1): 66-71.
20. Woo S, Cashman E, Lerman MA. Human papillomavirus-associated oral intraepithelial neoplasia. Modern Pathol. 2013; 26: 1288-97.
21. Liu H, Li J, Diao M, Cai Z, Yang J, Zeng Y. Statiscal analysis of human papillomavirus in a subset of upper aerodigestive tract tumors. J Med Virol. 2013; 85(10): 1175-85.
22. Buelvas A, Agudelo A. Gradiente social, envejecimiento y diagnóstico tardio en cancer oral. Rev Fac Nac Salud Publica. 2011; 29(3): 320-8.
23. Mayeaux J, Khan. Nongenital Human Papillomavirus Disease. Obstet Gynecol Clin N Am. 2013; 40(2): 317-37.
24. Sand L, Jalouli J. Viruses and oral cancer: is there a link? Microbes Infect. 2014; 16(5): 371-8.
25. Mascarehasing A, Papini L, Laguardia A, de Resende C, de Souza P, Silva E. Assesing oral brushing tecnique as a source to collect DNA and its use in detecting human papillomavirus. Pathol Res Pract. 2013; 209(5): 291-5.
26. Mendelsohn A, Lai C, Shintaky I, Elashoff D, Dubinett S, Abemayor E, St John MA. Histopathologic findings of HPV and p16 positive HNSCC Laryngoscope. 2010; 120(9): 1788-94.
27. Martin D, Gutkin J. Human tumor-associated viruses and new insights into the molecular mechanism of cancer. Oncogene. 2008; 27: 31-42.
28. Pytynia K, Dahlstrom K, Sturgis E. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014; 50: 380-6.
29. Osazuwa-Peters N. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States: Do we need a broader vaccine policy? Vaccine. 2013; 31: 5500-5.
30. Nelke K, Lysenko L, Leszcyszyn J, Gerber H. Humn papillomavirus and its influence on head and neck cancer predisposition. Postepy Hig Med Dosw. 2013; 67: 610-6.
31. World Health Organization. International Agency for Research on Cancer. [Online]; 2012 [cited 2014 Jun] Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. © 2024.
